Transcatheter Mitral Valve Chordal Repair: Current Indications and Future Perspectives
Authors:
Open Access
- 4 September 2019
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Cardiovascular Medicine
- Vol. 6, 128
Abstract
Transcatheter Mitral Valve Repair (TMVRe) technologies constitute a rapidly expanding field, and have the potential of being adopted as a valuable alternative to surgery in selected patients. TMVRe devices can be distinguished depending on the targeted part of the Mitral Valve (MV) apparatus. Standard classification includes leaflet repair, direct/indirect annuloplasty, chordal repair, and ventricular/chamber remodeling devices. We present the current device situation on chordal repair technologies. Nowadays, transapical off-pump beating heart chordal implantation procedure has become a safe and reproducible option for Degenerative Mitral Regurgitation (DMR). Besides the truly minimally-invasiveness of the procedure, another unique advantage offered by a beating-heart chordal implantation is the real-time assessment of chordal length adjustment during heart cycle with a normally filled left ventricle. Currently, one system is commercially available in Europe, the NeoChord DS 1000 (NeoChord, Inc., St. Louis Park, MN) and the Harpoon TDS-5 (Edwards Lifesciences, Irvine, CA) should become available soon. There is also a diffuse and strong interest to move from a transapical procedure toward a fully transcatheter (transfemoral and transeptal) procedure as shown by the increased number of preclinical programs under development. Interestingly, to achieve outcomes that equate to those of open surgery in DMR, transcatheter therapies will need to follow rigid indications due to strict patient selection criteria for each device, or adopt multiple techniques in a single repair procedure for complex MV disease. Continuous analysis of current clinical results together with future dedicated trial will be of extreme importance to foster the new and upcoming field of transcatheter MV therapy technology development.Keywords
This publication has 28 references indexed in Scilit:
- The dynamic cardiac biosimulator: A method for training physicians in beating-heart mitral valve repair proceduresThe Journal of Thoracic and Cardiovascular Surgery, 2018
- CT for the Transapical Off-Pump Mitral Valve Repair With Neochord Implantation ProcedureJACC: Cardiovascular Imaging, 2017
- Patient-Specific Ventricular Access Site Selection for the NeoChord Mitral Valve Repair ProcedureThe Annals of Thoracic Surgery, 2017
- Transapical Beating-Heart Mitral Valve Repair With an Expanded Polytetrafluoroethylene Cordal Implantation DeviceCirculation, 2016
- Transapical off-pump mitral valve repair with Neochord implantation: Early clinical resultsInternational Journal of Cardiology, 2016
- Transapical off-pump mitral valve repair with Neochord Implantation (TOP-MINI): step-by-step guide2015
- Acute safety and efficacy of the NeoChord procedureInteractive CardioVascular and Thoracic Surgery, 2015
- Off-Pump Transapical Implantation of Artificial Neo-Chordae to Correct Mitral RegurgitationJACC, 2014
- Beating-heart implantation of adjustable length mitral valve chordae: acute and chronic experience in an animal modelEuropean Journal of Cardio-Thoracic Surgery, 2011
- Mitral Regurgitation2009